We are live on
!
Find out more
Alkeon Capital Management Portfolio holdings
AUM
$59.5B
1-Year Est. Return
51.63%
This Fund
S&P 500
This Quarter
Est. Return
+21.95%
1 Year Est. Return
+51.63%
3 Year Est. Return
+162.63%
5 Year Est. Return
+168.42%
10 Year Est. Return
+1,374.92%
AUM
$60B
AUM Growth
+$12B
(+25%)
Cap. Flow
+$3B
Cap. Flow
% of AUM
5.01%
Top 10 Holdings %
Top 10 Hldgs %
64.97%
Holding
116
New
10
Increased
33
Reduced
21
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$558M |
| 2 |
Oracle
ORCL
|
+$407M |
| 3 |
Alibaba
BABA
|
+$192M |
| 4 |
Vistra
VST
|
+$148M |
| 5 |
Analog Devices
ADI
|
+$104M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$329M |
| 2 |
Amazon
AMZN
|
+$246M |
| 3 |
Okta
OKTA
|
+$162M |
| 4 |
TSMC
TSM
|
+$109M |
| 5 |
Equinix
EQIX
|
+$106M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.76% |
| 2 | Consumer Discretionary | 6.01% |
| 3 | Communication Services | 5.17% |
| 4 | Financials | 2.85% |
| 5 | Industrials | 2.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
BioCryst Pharmaceuticals
BCRX
$2.4B
| $51.2M | 0.09% |
5,714,021
-1,500,000
| -21% | -$14M |
|
77
Insmed
INSM
$28.6B
| $50.3M | 0.08% |
+500,000
| New | +$38.2M |
|
78
KE Holdings
BEKE
$18.8B
| $49.2M | 0.08% |
2,772,723
-1,500,000
| -35% | -$28.9M |
|
|
79
PUT
Oracle
ORCL
$423B
| $48.1M | 0.08% |
+220,000
| New | +$35.5M |
|
80
Oric Pharmaceuticals
ORIC
$1.4B
| $45.7M | 0.08% |
4,504,096
+500,000
| +12% | +$3.36M |
|
81
argenx
ARGX
$54.1B
| $41.3M | 0.07% |
75,000
| – | – |
|
|
82
PUT
Alphabet (Google) Class A
GOOGL
$4.33T
| $40.5M | 0.07% |
+230,000
| New | +$37.6M |
|
83
Toast
TOST
$19.9B
| $39.9M | 0.07% |
900,000
+400,000
| +80% | +$15.7M |
|
|
84
Okta
OKTA
$25.8B
| $38M | 0.06% |
380,000
-1,520,000
| -80% | -$162M |
|
85
Astera Labs
ALAB
$58B
| $36.2M | 0.06% |
400,000
| – | – |
|
86
CALL
Grayscale Bitcoin Trust
GBTC
$9.76B
| $33.9M | 0.06% |
+400,000
| New | +$31.1M |
|
87
NVIDIA
NVDA
$5.42T
| $33.4M | 0.06% |
211,439
-360,000
| -63% | -$45.3M |
|
|
OS
88
DELISTED
OneStream Inc
OS
| $26.9M | 0.04% |
950,000
-1,576,261
| -62% | -$39.3M |
|
|
HNGE
89
Hinge Health
HNGE
$7.21B
| $19.5M | 0.03% |
+376,011
| New | +$15.2M |
|
90
Iris Energy
IREN
$14.7B
| $14.6M | 0.02% |
+1,000,000
| New | +$8.12M |
|
|
MREO
91
Mereo BioPharma
MREO
$47.3M
| $12.7M | 0.02% |
4,698,100
| – | – |
|
92
Apple
AAPL
$4.57T
| $11.6M | 0.02% |
56,627
| – | – |
|
93
Keros Therapeutics
KROS
$221M
| $11.4M | 0.02% |
850,511
| – | – |
|
94
JFrog
FROG
$10.8B
| $9.41M | 0.02% |
214,425
+200,000
| +1,386% | +$7.6M |
|
95
dLocal
DLO
$4.24B
| $9.34M | 0.02% |
823,837
| – | – |
|
96
Applied Materials
AMAT
$428B
| $8.24M | 0.01% |
45,000
| – | – |
|
97
Sony
SONY
$138B
| $7.16M | 0.01% |
275,000
| – | – |
|
98
ASML
ASML
$669B
| $5.21M | 0.01% |
6,500
| – | – |
|
99
Paylocity
PCTY
$7.98B
| $4.47M | 0.01% |
24,683
| – | – |
|
100
PMV Pharmaceuticals
PMVP
$63.5M
| $2.48M | ﹤0.01% |
2,342,373
| – | – |
|
Similar funds
QCM
NAMI
Alkeon Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, Alkeon Capital Management held 116 positions worth $60B, up 25% from $48B the previous quarter. Its ten largest holdings account for 65% of the portfolio.
Alkeon Capital Management deployed $3B of net new capital in Q2 2025, opening 10 new positions and adding to 33 existing holdings. Its largest new stake was Oracle: 2,520,000 shares worth $551M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $329M trimmed.
- Alkeon Capital Management's largest Q2 2025 buy was Oracle: 2,520,000 shares worth $551M.
- Alkeon Capital Management added most to Alphabet (Google) Class A in Q2 2025, an estimated $558M increase.
- Alkeon Capital Management's biggest Q2 2025 reduction was Meta Platforms (Facebook), cutting an estimated $329M.
- Alkeon Capital Management fully exited Celestica in Q2 2025, selling an estimated $96.9M.
- Alkeon Capital Management's ten largest holdings make up 65% of its $60B portfolio in Q2 2025.
- Alkeon Capital Management opened 10 new positions and closed 13 in Q2 2025.
- Alkeon Capital Management's portfolio value rose 25% quarter-over-quarter to $60B.
Based on Alkeon Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.